Clinical Trials Directory

Trials / Completed

CompletedNCT07496320

Critical Food Ingredients on Immunocompetence to Prevent the Risk and Development of Obesity/Metabolic Syndrome

Study of Replacement of Critical Ingredients in Cookies on Immunocompetence in Healthy Population for the Prevention of Risk and Development of Obesity/Metabolic Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
IMDEA Food · Academic / Other
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

Double-blind cross-over intervention where the volunteers were randomized into two groups who, after receiving nutritional counseling, received two formulations in the form of a cookie: Group 1, commercial formulation and Group 2, a C. quinoa-based formulation for 12 days. Volunteers received nutritional advice and did not undergo dietary limitation(s) along the study periods. After the first period, volunteers underwent a washout stage before being included in the group to receive the opposite treatment to that received in the first stage. Blood and fecal samples were taken at both initial (i.e., visit 1, visit V3) and final (visit V2, visit 4) check-up visits from the volunteers at each study period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAdministration of a commercial cookie formulationVolunteers received two cookies - 1st a commercial formulation and 2nd a novel formulation
DIETARY_SUPPLEMENTImmunonutritional_2Volunteers receive two cookies - 1st a novel formulation and 2nd a commercial formulation

Timeline

Start date
2024-10-23
Primary completion
2024-10-23
Completion
2024-10-23
First posted
2026-03-27
Last updated
2026-03-27

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07496320. Inclusion in this directory is not an endorsement.

Critical Food Ingredients on Immunocompetence to Prevent the Risk and Development of Obesity/Metabolic Syndrome (NCT07496320) · Clinical Trials Directory